Skip to main content

MANAGING WITH STYLE: THE EFFECT OF MANAGERS ON FIRM POLICIES



MANAGING WITH STYLE: THE EFFECT OF MANAGERS ON FIRM POLICIES*

Marianne Bertrand and Antoinette Schoar

This paper investigates whether and how individual managers affect corpo rate behavior and performance. We construct amanager-firm matched panel data set which enables us to track the top managers across different firms over time.

We find that manager fixed effects matter for a wide range of corporate decisions.

A significant extent of the heterogeneity in investment, financial, and organiza tional practices of firms can be explained by the presence of manager fixed effects.

JOURNAL

managers. to manager

fixed

I. Introduction

I would have said it was capital, history, the name of the about the guy at the top. I am very much a process

style is significantly related

Moreover, fixed effects

in performance higher compen

management

and that managers with higher performance

sation and are more likely to be found in better governed firms. In a final step, we tie back these findings to observable managerial characteristics. We find that executives from earlier birth cohorts appear on average to be more conservative;

on the other hand, managers who hold an MBA degree seem to follow on average

participants

at Northwestern

of Management

of Technology, the University of Chicago

Kevin J. Murphy and Robert Parrino for generously providing us with their data.

Jennifer Fiumara and Michael McDonald provided excellent research E-mail: marianne.bertrand@gsb.uchicago.edu; aschoar@mit.edu.

? 2003 by the President and Fellows of Harvard College and the Massachusetts

Technology.

The Quarterly Journal of Economics, November 2003

assistance.

Institute of

1169

effects receive

we show

Popular posts from this blog

Elizabeth Holmes Discusses Theranos at WSJDLive 2015

Elizabeth Holmes Discusses Theranos at WSJDLive 2015 Elizabeth Holmes Discusses Theranos at WSJDLive 2015 At the WSJDLive 2015 conference, Theranos founder and CEO Elizabeth Holmes discusses her company's proprietary technologies, the FDA's inspection of its facilities, and the assertion that her company was too quick to market its products.